Nishijo Daigo, Yagi Hiroki, Akiyama Nana, Takeda Norifumi, Ando Masahiko, Yamauchi Haruo, Takeda Norihiko, Komuro Issei
Department of Cardiovascular Medicine Graduate School of Medicine The University of Tokyo, Tokyo, Japan.
Marfan Syndrome Center The University of Tokyo Hospital, Tokyo, Japan.
Case Rep Genet. 2024 Aug 16;2024:4281972. doi: 10.1155/2024/4281972. eCollection 2024.
Nonsyndromic hereditary thoracic aortic aneurysm and dissection (TAAD) is an autosomal dominant disease; however, it is frequently difficult to identify the causative genes. We report in this study a 33-year-old Japanese male with TAAD (Stanford type A) that is complicated with severe aortic regurgitation. There was no family history of aortic diseases in the patient nor any specific clinical features suggestive of connective tissue diseases, such as Marfan syndrome. Genetic testing identified candidate causative variants in two different genes: (c.4819G > A, p.[Gly1607Ser]) and (c.365G > A, p.[Arg122His]). Familial cosegregation analysis revealed that the novel de novo variant was present only in the proband, and the variant was also found in his nonaffected mother, and thus the variant was classified as likely pathogenic. is a causative gene for nonsyndromic TAAD that requires careful management; however, the number of reports is limited. Accumulating data on the pathogenicity of rare variants by performing a comprehensive pedigree analysis would help establish better treatment strategies for life-threatening hereditary TAAD cases.
非综合征性遗传性胸主动脉瘤和夹层(TAAD)是一种常染色体显性疾病;然而,致病基因往往难以确定。我们在本研究中报告了一名33岁的日本男性TAAD患者(斯坦福A型),该患者合并严重主动脉瓣关闭不全。患者无主动脉疾病家族史,也无任何提示结缔组织疾病(如马凡综合征)的特定临床特征。基因检测在两个不同基因中发现了候选致病变异:(c.4819G>A,p.[Gly1607Ser])和(c.365G>A,p.[Arg122His])。家族共分离分析显示,新的新发变异仅存在于先证者中,而该变异也在其未受影响的母亲中发现,因此该变异被分类为可能致病。是需要谨慎管理的非综合征性TAAD的致病基因;然而,相关报告数量有限。通过进行全面的家系分析积累罕见变异致病性的数据,将有助于为危及生命的遗传性TAAD病例制定更好的治疗策略。